Search for other papers by Nima Mohammadzadeh in
Current site
Google Scholar
PubMed
Search for other papers by Behrooz Sadeghi Kalani in
Current site
Google Scholar
PubMed
Search for other papers by Shahin Bolori in
Current site
Google Scholar
PubMed
Search for other papers by Azadeh Azadegan in
Current site
Google Scholar
PubMed
Search for other papers by Afsaneh Gholami in
Current site
Google Scholar
PubMed
Search for other papers by Rokhsareh Mohammadzadeh in
Current site
Google Scholar
PubMed
Search for other papers by Faramarz Masjedian Jazi in
Current site
Google Scholar
PubMed
As an important global health challenge, diarrhea kills nearly two million people each year. Postinfectious irritable bowel syndrome (IBS) usually manifests itself as the diarrhea-predominant subtype. Small intestinal bacterial overgrowth has been observed more frequently in patients with IBS compared to healthy controls. However, the pathophysiology of IBS is not fully understood, and based on recent evidences, altered gut microbiota is involved in the pathogenesis of IBS. Therefore, we aimed to compare the microbiome in hospitalized patients with diarrhea and healthy individuals. Thirty patients and 10 healthy controls were included into this case–control study. Microbial count was performed using quantitative real-time polymerase chain reaction method using bacterial 16S rRNA gene. Clostridium cluster IV and Bacteroides were significantly more frequent in the patients compared with the healthy individuals (p = 0.02 and 0.023, respectively). However, the quantity of Enterococcus and Bifidobacterium groups were significantly higher in healthy controls than in diarrheal group (p = 0.000076 and 0.001, respectively). The results showed that the number of bacteria in all bacterial groups was significantly different between healthy individuals and diabetic group, whereas the difference between the healthy group and IBS was not significant for Bifidobacterium group. The findings of this study outlined the relationship between diarrhea, IBS, and diabetes disease and bacterial composition. It could be concluded that modifying the bacterial composition by probiotics can be helpful in the control and management of the mentioned disease.
-
1.
Ayala, F. R. , Bauman, C. , Cogliati, S. , Leñini, C. , Bartolini, M. , Grau, R. : Microbial flora, probiotics, Bacillus subtilis and the search for a long and healthy human longevity. Microb Cell 4, 133–136 (2017).
-
2.
Lee, B. J. , Bak, Y.-T. : Irritable bowel syndrome, gut microbiota and probiotics. J Neurogastroenterol Motil 17, 252–266 (2011).
-
3.
Farahani, N. N. , Jazi, F. M. , Nikmanesh, B. , Asadolahi, P. , Kalani, B. S. , Amirmozafari, N. : Prevalence and antibiotic susceptibility patterns of Salmonella and Shigella species isolated from pediatric diarrhea in Tehran. Arch Pediat Inf Dis 6, e57328 (2018).
-
4.
Ohman, L. , Simren, M. : New insights into the pathogenesis and pathophysiology of irritable bowel syndrome. Dig Liver Dis 39, 201–215 (2007).
-
5.
Lovell, R. M. , Ford, A. C. : Global prevalence of and risk factors for irritable bowel syndrome: A meta-analysis. Clin Gastroenterol Hepatol 10, 712–721.e4 (2012).
-
6.
Sedighi, M. , Razavi, S. , Navab-Moghadam, F. , Khamseh, M. E. , Alaei-Shahmiri, F. , Mehrtash, A. , Amirmozafari, N. : Comparison of gut microbiota in adult patients with type 2 diabetes and healthy individuals. Microb Pathog 111, 362–369 (2017).
-
7.
Drossman, D. A. , Camilleri, M. , Mayer, E. A. , Whitehead, W. E. : AGA technical review on irritable bowel syndrome. Gastroenterology 123, 2108–2131 (2002).
-
8.
Chey, W. D. , Kurlander, J. , Eswaran, S. : Irritable bowel syndrome: A clinical review. JAMA 313, 949–958 (2015).
-
9.
Simrén, M. , Axelsson, J. , Gillberg, R. , Abrahamsson, H. , Svedlund, J. , Björnsson, E. S. : Quality of life in inflammatory bowel disease in remission: The impact of IBS-like symptoms and associated psychological factors. Am J Gastroenterol 97, 389–396 (2002).
-
10.
Bercik, P. , Verdu, E. F. , Collins, S. M. : Is irritable bowel syndrome a low-grade inflammatory bowel disease? Gastroenterol Clin North Am 34, 235–245 (2005).
-
11.
Simrén, M. , Svedlund, J. , Posserud, I. , Björnsson, E. S. , Abrahamsson, H. : Health-related quality of life in patients attending a gastroenterology outpatient clinic: Functional disorders versus organic diseases. Clin Gastroenterol Hepatol 4, 187–195 (2006).
-
12.
Ohman, L. , Simrén, M. : Pathogenesis of IBS: Role of inflammation, immunity and neuroimmune interactions. Nat Rev Gastroenterol Hepatol 7, 163–173 (2010).
-
13.
Dupont, H. : Review article: Evidence for the role of gut microbiota in irritable bowel syndrome and its potential influence on therapeutic targets. Aliment Pharmacol Ther 39, 1033–1042 (2014).
-
14.
Ghoshal, U. C. , Kumar, S. , Mehrotra, M. , Lakshmi, C. , Misra, A. : Frequency of small intestinal bacterial overgrowth in patients with irritable bowel syndrome and chronic non-specific diarrhea. J Neurogastroenterol Motil 16, 40–46 (2010).
-
15.
Karantanos, T. , Markoutsaki, T. , Gazouli, M. , Anagnou, N. P. , Karamanolis, D. G. : Current insights in to the pathophysiology of irritable bowel syndrome. Gut Pathog 2, 3 (2010).
-
16.
Kassinen, A. , Krogius-Kurikka, L. , Mäkivuokko, H. , Rinttilä, T. , Paulin, L. , Corander, J. , Malinen, E. , Apajalahti, J. , Palva, A. : The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology 133, 24–33 (2007).
-
17.
Posserud, I. , Stotzer, P.-O. , Björnsson, E. S. , Abrahamsson, H. , Simrén, M. : Small intestinal bacterial overgrowth in patients with irritable bowel syndrome. Gut 56, 802–808 (2007).
-
18.
Carroll, I. M. , Ringel-Kulka, T. , Keku, T. O. , Chang, Y.-H. , Packey, C. D. , Sartor, R. B. , Ringel, Y. : Molecular analysis of the luminal-and mucosal-associated intestinal microbiota in diarrhea-predominant irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol 301, G799–G807 (2011).
-
19.
Carroll, I. M. , Ringel-Kulka, T. , Siddle, J. P. , Ringel, Y. : Alterations in composition and diversity of the intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome. Neurogastroenterol Motil 24, 521–530 (2012).
-
20.
Halvorson, H. A. , Schlett, C. D. , Riddle, M. S. : Postinfectious irritable bowel syndrome – A meta-analysis. Am J Gastroenterol 101, 1894–1899 (2006).
-
21.
Ortiz-Lucas, M. , Tobias, A. , Saz, P. , Sebastián, J. J. : Effect of probiotic species on irritable bowel syndrome symptoms: A bring up to date meta-analysis. Rev Esp Enferm Dig 105, 19–36 (2013).
-
22.
Behrooz, S. K. , Lida, L. , Ali, S. , Mehdi, M. , Rasoul, M. , Elnaz, O. , Farid, B. T. , Gholamreza, I. : Study of MazEF, sam, and phd-doc putative toxin–antitoxin systems in Staphylococcus epidermidis. Acta Microbiol Immunol Hung 65, 81–91 (2018).
-
23.
Kalani, B. S. , Irajian, G. , Lotfollahi, L. , Abdollahzadeh, E. , Razavi, S. : Putative type II toxin-antitoxin systems in Listeria monocytogenes isolated from clinical, food, and animal samples in Iran. Microb Pathog 122, 19–24 (2018).
-
24.
Swidsinski, A. , Loening-Baucke, V. , Verstraelen, H. , Osowska, S. , Doerffel, Y. : Biostructure of fecal microbiota in healthy subjects and patients with chronic idiopathic diarrhea. Gastroenterology 135, 568–579 (2008).
-
25.
Sokol, H. , Pigneur, B. , Watterlot, L. , Lakhdari, O. , Bermúdez-Humarán, L. G. , Gratadoux, J. J. , Blugeon, S. , Bridonneau, C. , Furet, J. P. , Corthier, G. , Grangette, C. , Vasquez, N. , Pochart, P. , Trugnan, G. , Thomas, G. , Blottière, H. M. , Doré, J. , Marteau, P. , Seksik, P. , Langella, P. : Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A 105, 16731–16736 (2008).
-
26.
Vrakas, S. , Mountzouris, K. C. , Michalopoulos, G. , Karamanolis, G. , Papatheodoridis, G. , Tzathas, C. , Gazouli, M. : Intestinal bacteria composition and translocation of bacteria in inflammatory bowel disease. PLoS One 12, e0170034 (2017).
-
27.
Maukonen, J. , Satokari, R. , Mättö, J. , Söderlund, H. , Mattila-Sandholm, T. , Saarela, M. : Prevalence and temporal stability of selected clostridial groups in irritable bowel syndrome in relation to predominant faecal bacteria. J Med Microbiol 55, 625–633 (2006).
-
28.
Rajilić-Stojanović, M. , Biagi, E. , Heilig, H. G. , Kajander, K. , Kekkonen, R. A. , Tims, S. , de Vos, W. M. : Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology 141, 1792–1801 (2011).
-
29.
Kerckhoffs, A. P. , Samsom, M. , van der Rest, M. E. , de Vogel, J. , Knol, J. , Ben-Amor, K. , Akkermans, L. M. : Lower Bifidobacteria counts in both duodenal mucosa-associated and fecal microbiota in irritable bowel syndrome patients. World J Gastroenterol 15, 2887–2892 (2009).
-
30.
Si, J.-M. , Yu, Y.-C. , Fan, Y.-J. , Chen, S.-J. : Intestinal microecology and quality of life in irritable bowel syndrome patients. World J Gastroenterol 10, 1802–1805 (2004).
-
31.
Zhuang, X. , Xiong, L. , Li, L. , Li, M. , Chen, M. : Alterations of gut microbiota in patients with irritable bowel syndrome: A systematic review and meta-analysis. J Gastroenterol Hepatol 32, 28–38 (2017).
-
32.
Carroll, I. M. , Ringel-Kulka, T. , Siddle, J. P. , Klaenhammer, T. R. , Ringel, Y. : Characterization of the fecal microbiota using high-throughput sequencing reveals a stable microbial community during storage. PLoS One 7, e46953 (2012).
-
33.
Parkes, G. , Rayment, N. B. , Hudspith, B. N. , Petrovska, L. , Lomer, M. C. , Brostoff, J. , Whelan, K. , Sanderson, J. D. : Distinct microbial populations exist in the mucosa-associated microbiota of sub-groups of irritable bowel syndrome. Neurogastroenterol Motil 24, 31–39 (2012).
-
34.
Remely, M. , Dworzak, S. , Hippe, B. , Zwielehner, J. , Aumüller, E. , Brath, H. , Haslberger, A. : Abundance and diversity of microbiota in type 2 diabetes and obesity. J Diabetes Metab 4, 2 (2013).
-
35.
Murri, M. , Leiva, I. , Gomez-Zumaquero, J. M. , Tinahones, F. J. , Cardona, F. , Soriguer, F. , Queipo-Ortuño, M. I. : Gut microbiota in children with type 1 diabetes differs from that in healthy children: A case-control study. BMC Med 11, 46 (2013).
-
36.
Larsen, N. , Vogensen, F. K. , van den Berg, F. W. , Nielsen, D. S. , Andreasen, A. S. , Pedersen, B. K. , Al-Soud, W. A. , Sørensen, S. J. , Hansen, L. H. , Jakobsen, M. : Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One 5, e9085 (2010).
-
37.
Lambeth, S. M. , Carson, T. , Lowe, J. , Ramaraj, T. , Leff, J. W. , Luo, L. , Bell, C. J. , Shah, V. O. : Composition, diversity and abundance of gut microbiome in prediabetes and type 2 diabetes. J Diabetes Obes 2, 1–7 (2015).
-
38.
Rebolledo, C. , Cuevas, A. , Zambrano, T. , Acuña, J. J. , Jorquera, M. A. , Saavedra, K. , Martínez, C. , Lanas, F. , Serón, P. , Salazar, L. A. , Saavedra, N. : Bacterial community profile of the gut microbiota differs between hypercholesterolemic subjects and controls. BioMed Res Int 2017, 8127814 (2017).
Editorial Office:
Akadémiai Kiadó Zrt.
Budafoki út 187-187, A/3, H-1117 Budapest, Hungary
Editorial Correspondence:
Acta Microbiologica et Immunologica Hungarica
Institute of Medical Microbiology
Semmelweis University
P.O. Box 370
H-1445 Budapest, Hungary
Phone: + 36 1 459 1500 ext. 56101
Fax: (36 1) 210 2959
E-mail: amih@med.semmelweis-univ.hu
Indexing and Abstracting Services:
- Biological Abstracts
- BIOSIS Previews
- CAB Abstracts
- CABELLS Journalytics
- Chemical Abstracts
- Global Health
- Index Medicus
- Index Veterinarius
- Medline
- Referativnyi Zhurnal
- SCOPUS
- Science Citation Index Expanded
| 2023 | |
|---|---|
| Web of Science | |
| Journal Impact Factor | 1.3 |
| Rank by Impact Factor | Q4 (Immunology) |
| Journal Citation Indicator | 0.31 |
| Scopus | |
| CiteScore | 2.3 |
| CiteScore rank | Q3 (Infectious Diseases) |
| SNIP | 0.389 |
| Scimago | |
| SJR index | 0.308 |
| SJR Q rank | Q3 |
| Acta Microbiologica et Immunologica Hungarica | |
|---|---|
| Publication Model | Hybrid |
| Submission Fee | none |
| Article Processing Charge | 1100 EUR/article (only for OA publications) |
| Regional discounts on country of the funding agency | World Bank Lower-middle-income economies: 50% World Bank Low-income economies: 100% |
| Further Discounts | Editorial Board / Advisory Board members: 50% Corresponding authors, affiliated to an EISZ member institution subscribing to the journal package of Akadémiai Kiadó: 100% |
| Subscription fee 2025 | Online subsscription: 772 EUR / 848 USD Print + online subscription: 860 EUR / 944 USD |
| Subscription Information | Online subscribers are entitled access to all back issues published by Akadémiai Kiadó for each title for the duration of the subscription, as well as Online First content for the subscribed content. |
| Purchase per Title | Individual articles are sold on the displayed price. |
| Acta Microbiologica et Immunologica Hungarica | |
|---|---|
| Language | English |
| Size | A4 |
| Year of Foundation |
1954 |
| Volumes per Year |
1 |
| Issues per Year |
4 |
| Founder | Magyar Tudományos Akadémia |
| Founder's Address |
H-1051 Budapest, Hungary, Széchenyi István tér 9. |
| Publisher | Akadémiai Kiadó |
| Publisher's Address |
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245. |
| Responsible Publisher |
Chief Executive Officer, Akadémiai Kiadó |
| ISSN | 1217-8950 (Print) |
| ISSN | 1588-2640 (Online) |
Monthly Content Usage
| Abstract Views | Full Text Views | PDF Downloads | |
|---|---|---|---|
| Apr 2024 | 46 | 0 | 0 |
| May 2024 | 51 | 0 | 0 |
| Jun 2024 | 66 | 0 | 1 |
| Jul 2024 | 30 | 0 | 0 |
| Aug 2024 | 101 | 1 | 2 |
| Sep 2024 | 58 | 0 | 0 |
| Oct 2024 | 25 | 0 | 0 |
Copyright Akadémiai Kiadó AKJournals is the trademark of Akadémiai Kiadó's journal publishing business branch.